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Summary. Recent studies in sub-Saharan Africa have shown that fertility is
reduced among HIV-infected women compared with uninfected women. The
size and pattern of this fertility reduction has important implications for
antenatal clinic-based surveillance of the epidemic and also for estimates and
projections of the demographic impact of the epidemic. This paper examines
the association between HIV and fertility in Kisesa, a rural area in Tanzania,
where HIV prevalence among adults is about 6% and gradually increasing.
The analysis is based on data obtained through a demographic surveillance
system in Kisesa during 1994–98 and two large sero-surveys of all residents
in 1994–95 and 1996–97. The HIV-associated fertility reduction among
women was investigated by estimating fertility rates by HIV status and
prevalence rates by fertility status. A substantial reduction (29%) was
observed in fertility among HIV-infected women compared with HIV-
uninfected women. The fertility reduction was most pronounced during the
terminal stages of infection, but no clear association with duration of
infection was observed. Use of modern contraception was higher among
HIV-infected women. However, both among contracepting and non-
contracepting women, a substantial reduction in fertility was seen among
HIV-infected women.
Introduction
A growing body of evidence now exists to support the hypothesis of reduced fertility
among HIV-infected women relative to their HIV-uninfected peers. Cohort studies in
rural Uganda and urban Zaire have shown signiﬁcant and fairly consistent fertility
reductions among HIV-infected women. In Rakai, Uganda, the relative risk
of an infected woman giving birth was 0·8 relative to an uninfected woman
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(Sewankambo et al., 1994). In Masaka, Uganda, the overall age-adjusted fertility rate
in HIV-infected women was 0·74 times that of uninfected women (Carpenter et al.,
1997). In Kinshasa, Zaire, the fertility rate ratio in a cohort of women recruited from
hospital following the delivery of a child was 0·77, adjusted for contraceptive use
(Ryder et al., 1991).
A diﬀerence in fertility rates between HIV-infected and uninfected women has
implications for the measurement of HIV prevalence in populations. A search of the
US Bureau of the Census, HIV/AIDS surveillance database, showed that over 60% of
studies estimating HIV prevalence in the developing world are based on blood
samples taken from antenatal women (US Bureau of the Census, 1998). If fertility
diﬀerentials by HIV status are not taken into consideration when interpreting HIV
prevalence estimates from sentinel surveillance of antenatal clinic attendees, serious
underestimates could be made of the total number of women infected. Fertility
diﬀerentials by HIV status also have implications for orphanhood estimates and
projections, as well as for the cost of mother-to-child transmission reduction
programmes.
HIV is known to have a direct impact on fertility due to biological factors
including increased risk of spontaneous abortions and stillbirths (Miotti et al., 1990;
Brocklehurst & French, 1998). In the later stages of the disease there is increased
amenorrhoea (Widy-Wirski et al., 1988). In men, it reduces spermatogenesis (Krieger
et al., 1991), and lower coital frequencies have been reported by couples in which the
male partner has begun to suﬀer from opportunistic infections (Dublin et al., 1993).
Behavioural responses to the epidemic may alter fertility in the whole population,
although they are likely to aﬀect HIV-positive women more than the HIV-negative,
contributing to observed fertility diﬀerentials. Studies in Uganda and Zimbabwe
indicated higher rates of widowhood, higher divorce rates as a result of knowledge or
suspicion of HIV infection in either partner, and lower re-marriage rates (Muzika-
Gapere & Ntozi, 1996; Gregson et al., 1997). A study in Zaire (Ryder et al., 1991)
noted higher rates of postpartum contraceptive use among HIV-positive women. On
the other hand, it has been suggested that some behavioural changes may cause
increases in fertility. For example, in Zimbabwe, decreases in breast-feeding have been
reported amongst women who know that the virus may be transmitted to infants
through breast milk (Gregson et al., 1997).
Although infection with HIV is generally thought to cause lower fertility, it is
also possible that reverse causation and selection eﬀects contribute to the observed
relationship. Many African societies place great importance on bearing children,
putting great pressure on women who experience diﬃculty in having children. A
study in Uganda (Ross et al., 1999) found that pre-existing diﬀerences in the
gravidity of women accounted for almost half of the observed diﬀerences in the
fertility of HIV-infected and uninfected women. A study in Gabon showed
age-adjusted HIV prevalence to be far higher among women with primary
infertility than among fertile women (Schrijvers et al., 1991). In Tanzania, HIV
prevalence was markedly higher among infertile women than among fertile women
after adjusting for age, residence and occupation (Favot et al., 1997). An association
was observed between past sexual behaviour and infertility problems, with infertile
women having higher numbers of lifetime sexual partners, more marital breakdowns
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and a higher level of exposure to sexually transmitted diseases. Another Ugandan
study also showed that women with HIV infection were more likely to have a history
of other STDs, which are a known cause of secondary infertility (Wagner et al.,
1994).
Another issue on which there is suggestive evidence, but only in a developed
country setting, is the temporality of the eﬀect of HIV on fertility. Lee found a
signiﬁcant eﬀect of duration of infection on fertility among American women with
AIDS (Lee et al., 2000). The relative risk of giving birth fell from 0·85 (95% CI 0·71,
1·03) at 7Y to 10 years before an AIDS diagnosis to 0·45 (95% CI 0·38, 0·55) in the
last 2Y years before the AIDS diagnosis. As the average time since infection is likely
to lengthen as the epidemic matures, the magnitude of the HIV-associated fertility
reduction could change with time.
This paper presents data from a large open cohort study in rural Tanzania
between 1994 and 1998. It aims to provide further insights into the relationship
between women’s HIV status and fertility by analysing fertility diﬀerentials by HIV
status and by comparing the HIV infection rates in pregnant women with those in all
women regardless of pregnancy status. The dynamics of the relationship between HIV
and fertility are also investigated, by looking at how fertility varies by duration and
severity (in terms of proximity to death) of HIV infection.
Background and methods
This study was carried out in the Kisesa ward of Mwanza region of North-west
Tanzania. The ward consists of a group of six dispersed villages and a slightly more
urbanized centre, and forms an administrative entity in its own right. Kisesa ward has
a population of approximately 20,000 and lies about 20 km east of Mwanza City, the
regional capital, on the main road to Kenya. The Sukuma are the largest ethnic group
in Kisesa, comprising more than 90% of the population. Farming is the main source
of income.
In 1994, a demographic surveillance system was set up in Kisesa. Each household
in the ward was visited and data on the demographic characteristics of all residents
were collected. Every 6 months each household was revisited and this information was
updated with new data about births and deaths among the residents and about
migrations to and from the area. By the end of 1998 ten surveillance visits had been
completed. In addition to demographic surveillance, an epidemiological survey was
undertaken during 1994 and 1995 of all adults between the ages of 15 and 44. Eligible
persons (i.e. all those born between 1950 and 1980 and listed as resident at a previous
surveillance visit) were asked to come to a central point in the village to be
interviewed with an extensive structured questionnaire. In addition, respondents were
asked to provide a blood sample for HIV testing. The survey was repeated 2 years
later, during 1996 and 1997, for all adults aged between 15 and 46 resident in the
area. Attendance at the ﬁrst and second surveys was 5820 (78·0%) and 6413 (79·5%)
respectively (Boerma et al., 1999). Details of the testing procedures used, along with
more detailed information on the data collection methods and study population, have
been published elsewhere (Boerma et al., 1999).
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Results
All women aged between 15 and 44, who were resident in Kisesa and present at two
or more demographic surveillance visits, are included in this fertility analysis. Data
were obtained from 7631 women with a mean duration of follow-up of 29·6 months.
Attendance at the two epidemiological surveys, among these women, was 2942 and
3308 in 1994–5 and 1996–7 respectively. The majority of women who did not
participate in the surveys were not listed as resident in the demographic surveillance
system at the time of the survey. The median age of the women was 26 years in the
ﬁrst survey and 27 years in the second. HIV results are available for all but seventeen
of the women in the ﬁrst survey and eleven in the second. This resulted in a total of
4139 women for whom at least one HIV test result was available. Female HIV
prevalence at the two surveys was 6·7% and 7·9%. HIV incidence between the two
surveys was 0·84 per 100 woman-years. HIV prevalence among men was lower at
5·0% and 5·1% at the ﬁrst and second surveys respectively, and HIV incidence was
0·73 per 100 man-years.
Table 1 shows the background association between women’s parity and HIV
status for the two surveys combined. A clear pattern is seen with nulliparous women
having the highest HIV prevalence at all ages with the exception of the 15–19 age
group, where childlessness is strongly associated with low levels of sexual activity.
Amongst teenagers, it is women of parity one and two who have the highest HIV
prevalence, but outside of this age group, lowest HIV prevalences are seen at highest
parities.
Fertility and HIV
Age-speciﬁc fertility rates (ASFRs) for women aged 15–44, by HIV status, are
shown in Table 2. These have been computed on the basis of births occurring up to
2 years after the last HIV test. Three groups of women are compared. The ﬁrst group
are women who tested negative at both sero-surveys. The second group consists of
those who were uninfected in 1994–5 but whose status in 1996–7 is unknown. The
third group are women followed up after a serology test showed them to be infected.
The inter-survey experience of the 33 women who sero-converted between the surveys
has not been included in this analysis.
Table 1. HIV prevalence by age and parity, both surveys combined
Age Parity
0 1–2 3–5 6+
15–19 0·9 3·7 0·0 
20–24 17·0 6·4 5·7 0·0
25–34 21·5 17·6 13·6 4·8
35+ 23·1 9·2 7·2 6·0
Age adjusted 5·9 9·4 11·3 5·6
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The total fertility rate (TFR) in the second group of women was 4·3, closer to the
rate for the initially infected than for those remaining negative throughout. This may
appear surprising, given the relatively low rate of sero-conversion observed in the
population, but women in this group are more mobile than those who were present for
both rounds of HIV testing. Mobility is associated with having fewer family ties,
including less stable marriage and lower fertility. Mobility and marital stability are both
considered risk factors for HIV (Caldwell et al., 1997; Ntozi, 1997; Boerma et al., 2002).
Age-speciﬁc fertility rates were also calculated for another highly mobile group:
the 3492 women aged 15–44 who were present at two or more demographic
surveillance visits but who did not have an HIV test result from either sero-survey.
Their ASFRs also fell between the rates of the women of known HIV status, and their
total fertility rate was 4·8.
The age-adjusted fertility rate ratio was calculated, treating the women in both the
ﬁrst two categories in Table 2 as uninfected. The resulting age-adjusted fertility rate
ratio was 0·71 for infected women compared with uninfected women.
HIV prevalence levels among all women aged 15–44 encountered in the two
epidemiological surveys and among women who were known to have been pregnant
during the inter-survey period are shown in Fig. 1. Women were classiﬁed as pregnant
if they gave birth during the inter-survey period or in the subsequent 9 months. For
women aged 20 and over, HIV prevalence was higher in both survey populations than
among the subgroup of pregnant women. This diﬀerence is statistically signiﬁcant
among women aged 20–39. Among women aged 15–19, a higher HIV prevalence was
found in pregnant women: 3·15% compared with 1·03% and 1·92% in all women at
the ﬁrst and second surveys respectively.
Fertility among HIV-infected women
The eﬀect of duration of HIV infection on fertility was examined by looking at
general fertility rates (GFR: births per 1000 women-years of observation) among
Table 2. Age-speciﬁc fertility rates per 1000 women-years, by HIV status in the two
surveys, based on demographic surveillance data
Uninfected at Uninfected at Infected or unknown at
Age group 1st and 2nd surveys 1st/unknown at 2nd survey 1st/infected at 2nd survey
ASFR Women-years ASFR Women-years ASFR Women-years
15–19 121 1998 82 368 166 30
20–24 292 1887 197 391 158 159
25–29 290 1718 211 284 152 243
30–34 256 1592 202 277 83 169
35–39 187 1329 87 139 55 91
40–44 91 1097 74 136 103 49
TFR 6·2 4·3 3·6
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infected women by year since they ﬁrst tested positive in this study, either in the ﬁrst
or second survey. The results are shown in Table 3. There is a suggestion of a modest
downward trend in the GFR with increasing time since ﬁrst positive HIV test, with
the exception of the fourth year. However, the ﬁnal year’s estimate must be
interpreted with caution. It is based on only 38 women-years’ observation and is
therefore prone to error, since the 65 women who survived for more than 3 years after
testing positive had on average been observed for only half of the fourth year.
The eﬀect of severity of infection on fertility was also investigated by comparing
the GFR during the period 1994–1998 among 271 HIV-infected women who survived
to the tenth surveillance visit with the GFR among 33 infected women who had died
before this visit. The GFR among survivors was 112 (based on 53 births in 473·4
women-years of observation), compared with a GFR of 29 for women who died
before the tenth round (who experienced one birth in the 34·2 person-years before
they died). This large and signiﬁcant diﬀerence gives an indication of the possible
Fig. 1. HIV prevalence among all women at surveys one and two and among pregnant
women in the inter-survey period.
Table 3. General fertility rates (per 1000 women-years, ages 15–44) by year since ﬁrst
HIV-positive test
Year n GFR
1 304 109·9
2 192 92·2
3 105 73·0
4 65 210·9
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eﬀect of HIV-associated illness on fertility. The eﬀects of women’s illness may also be
compounded by illness and death among their partners, since women who died were
more likely to have had partners at an advanced stage of HIV disease. At the time
of the ﬁrst survey, 6·4% of women were widowed in the population as a whole.
Among the HIV-infected women, 17·4% of those who survived to the tenth
surveillance visit were widowed compared with 25·0% of the women who died before
this time.
Fertility control by HIV status
General fertility rates for women aged 15–44, by HIV status and use of modern
contraception, are shown in Table 4. Contraceptive users are women who reported
current use of modern contraception at either the ﬁrst or second sero-surveys.
Non-users consist of women who attended at least one of the two surveys and did not
report current use of modern contraception at either survey. The 33 women who
sero-converted between the two surveys have been excluded from this table. The
proportion of women describing themselves as current users of contraception
increased from 5% to 6% between the surveys, but around 10% of HIV-positive
women were recorded as contraceptive users in both surveys. Current contraceptive
use is almost twice as high among HIV-positive women, but clearly both HIV-positive
and HIV-negative women do not use contraception consistently and continuously,
since the fertility rates of contraceptive users, though substantially lower than those
of non-users, are far from zero. Among both contraceptive users and non-users,
a substantial fertility reduction was seen among HIV-infected women (52% and
26% respectively).
Discussion
In a rural area in North-west Tanzania, the fertility of HIV-positive women compared
with HIV-negative women was reduced by 29%, after adjusting for diﬀerences in age
distribution. This eﬀect is slightly larger than that observed in other studies in
sub-Saharan Africa (Ryder et al., 1991; Sewankambo et al., 1994; Carpenter et al.,
1997), but of the same order of magnitude.
Table 4. General fertility rates (per 1000 women-years, ages 15–44) by use of modern
contraception and HIV status
HIV status Current use of modern contraception
Non-users Users All women
GFR Women-years GFR Women-years GFR Women-years
Negative 207·6 10,523 131·5 646 203·2 11,169
Positive 153·4 678 63·7 94 142·4 772
All women 204·4 11,201 122·9 740 199·3 11,941
Ratio +/- 0·74 0·48 0·70
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Contrary to the diﬀerential at older ages, the ASFR among infected women in the
age group 15–19 was 166 per 1000 women-years: higher than the rate of 121 recorded
among uninfected women under 20. This pattern was also seen in two Ugandan
studies: in Masaka (Carpenter et al., 1997), and in Rakai (Gray et al., 1998), but it
was not possible to tell if this pattern occurred in the Kinshasa study (Ryder et al.,
1991) due to the age grouping of the results.
Several studies in sub-Saharan Africa have compared the prevalence of HIV
among pregnant women from antenatal clinics with HIV prevalence among women in
the community from a population-based survey. In six out of seven of these studies
(Fort Portal, Uganda, 1998 (Kilian et al., 1999), Mwanza Town, Tanzania, 1991
(Kigadye et al., 1993; Kwesigabo et al., 1996), Ndola, Zambia, 1998 (Musonda et al.,
1999), Kinshasa, Zaire, 1996 (Fylkesnes, et al., 1998) and Yaounde, Cameroon, 1998
(Macauley et al., 1999)), the ratio of HIV prevalence in pregnant women compared
with that in all women ranged from 0·70 to 0·87. In one study carried out in Kisumu,
Kenya, in 1998 (Kahindo et al., 1999), the ratio was found to be 1·04. Attendance
rates at the clinics were estimated to be over 85% in the studies in Fort Portal,
Mwanza Town and Kinshasa. These rates are not available for the other studies.
However, evidence from DHS surveys suggests that antenatal clinic attendance rates
in these countries are of a similar order of magnitude. In the Kisesa study, the
experience of all pregnant women is captured, regardless of antenatal clinic
attendance, and the ratio of HIV prevalence in pregnant women to that of the general
female population of childbearing age is 0·79.
The reduction in fertility among HIV-infected women may have behavioural and
biological causes. Women with HIV infection may have less frequent sexual
intercourse and many may not have intercourse at all, especially if they are aﬀected
by opportunistic infections or if their partners die of AIDS. This suspicion cannot be
conﬁrmed using the data from Kisesa, since detailed data on sexual intercourse were
not collected. Women with HIV infection may also be more frequent users of
contraceptive methods, including condoms. In this study contraceptive use rates
among the HIV-positive were found to be double those of the HIV-negative. Very few
women in the Kisesa population were aware of their HIV status during the study
period. Less than 1% made use of the voluntary counselling and testing services
during the 1996–97 survey. It is therefore unlikely that contraceptive use in this group
was entirely motivated by awareness of infection status, although no information is
available on which women made use of the testing in order to conﬁrm this. Higher
rates of contraceptive use among the HIV-positive do not explain the entire fertility
diﬀerential, since the fertility diﬀerence between HIV-positive and HIV-negative
women persists amongst contraceptive users. If contraceptive use rates had been the
same in HIV-positive and HIV-negative women, the overall general fertility rate ratio
would be little changed, increasing from 0·70 to 0·73.
Biological eﬀects of HIV infection on fertility are likely to become stronger the
longer the infection persists, as was observed in a US study (Lee et al., 2000). The
current study found little evidence of larger reductions of fertility over time, with the
exception of the terminal year(s) of infection. An important limitation of this analysis
is that women are only categorized as infected after their ﬁrst positive HIV test result.
No attempt is made to estimate a likely infection date. If the biological association
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between duration of infection and fertility is non-linear, which seems plausible, this
would have aﬀected the results.
Ross et al. (1999) found in a study in rural Uganda that about half of the reduced
fertility among HIV-infected women was associated with lower pre-existing fertility,
and suggested this might be due to higher risk behaviour among women with
subfertility (Favot et al., 1997). In this study it was not possible to assess the potential
confounding eﬀect of subfertility prior to HIV infection on the association between
HIV and fertility due to the small number of incident cases. HIV incidence among
women with no birth in the last 5 years before the survey was not higher than that
in women who gave birth in the last 5 years.
In summary, this study in rural Tanzania shows a substantial reduction in fertility
among HIV-infected women compared with HIV-negative women. The fertility
reduction was most pronounced during the terminal stages of infection, but no clear
association with duration of infection was observed. To be able to assess to what
extent behavioural or biological factors and subfertility prior to infection with HIV
infection are responsible for the large diﬀerences observed in fertility of HIV-infected
and uninfected women, more detailed data on sexual behaviour are needed, especially
during the later stages of infection.
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